Compare Stocks
Compare up to 5 stocks side by side with metrics, growth rates, and performance charts
Select Stocks
ASND
EXEL
Add up to 3 more stocks
ASND
Ascendis Pharma A/S
+0.07%
$228.03+0.16Delayed quote: Oct 5, 2026, 4:00 PM EDT
Market Cap
$14.16B
52W Range
$186.05 - $282.15
EXEL
Exelixis, Inc.
+0.79%
$58.85+0.46Delayed quote: Oct 5, 2026, 4:00 PM EDT
Market Cap
$14.79B
52W Range
$33.76 - $61.14
| Metric | ||
|---|---|---|
| ValuationTTM multiples, at last close | ||
| P/E Ratio | 17.33 | 18.45 |
| Forward P/E | N/A | 16.75 |
| PEG Ratio | N/A | 0.36 |
| P/B Ratio | 8.64 | 8.02 |
| P/S Ratio | 11.59 | 6.07 |
| P/FCF Ratio | 36.61 | 12.77 |
| EV/EBITDA | 93.79 | 14.68 |
| Profitabilitytrailing twelve months | ||
| Gross Margin | 90.2% | 96.5% |
| Operating Margin | -18.9% | 39.9% |
| Net Margin | 71.1% | 35.3% |
| ROE | 53.0% | 46.7% |
| ROA | 33.3% | 34.5% |
| ROIC | 5.8% | 37.9% |
| Financial Healthlatest reported quarter | ||
| Current Ratio | 2.99 | 3.46 |
| Quick Ratio | 2.32 | 3.38 |
| Debt/Equity | 0.31 | 0.09 |
| Interest Coverage | -1.69 | N/A |
| Dividendstrailing dividends vs latest price | ||
| Dividend Yield | N/A | N/A |
| Payout Ratio | N/A | N/A |
| Yrs of Dividend Growth | 0 | 0 |
N/A includes missing data and metrics withheld while their applicability to the company is unverified. Bars show each value's size relative to the row's largest — a factual magnitude cue, not a rating. Tap a metric name for its full history.